AE Analysis Finds Low Rate of T-Cell Malignant Neoplasms in

Only 11 cases of adverse events (AEs) were reported over a 6-year time frame, the investigators found, following administration of chimeric antigen receptor T-cell therapy (CAR T).

Related Keywords

, Novartis , Event Reporting System , Kite Pharma , Image Credit , Chimeric Antigen Receptort Cell Therapy , Car T , Jama Oncology ,